# FDA Inspection 1046139 - Biomat USA Inc - February 21, 2018

Source: https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/47d4499a-dc8f-41fa-a487-889e1d828a68
Source feed: FDA_Inspections

> FDA Inspection 1046139 for Biomat USA Inc on February 21, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1046139
- Company Name: Biomat USA Inc
- Inspection Date: 2018-02-21
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 947809 - 2015-11-05](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/6c35babc-2ae1-4961-9d8d-d067f0e051ce)
- [FDA Inspection 829350 - 2013-04-26](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/f3b6479e-df60-4755-b855-d7305eae408a)
- [FDA Inspection 732609 - 2011-06-23](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/139d8a12-f8eb-4a0d-8dc6-13a96359d2c7)

Company: https://www.globalkeysolutions.net/companies/biomat-usa-inc/0a64e377-dd5b-46b4-8314-a68d1264cf32

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d